Cite
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
MLA
Chen, Grace L., et al. “Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.” JAMA: Journal of the American Medical Association, vol. 323, no. 14, Apr. 2020, pp. 1369–77. EBSCOhost, https://doi.org/10.1001/jama.2020.2477.
APA
Chen, G. L., Coates, E. E., Plummer, S. H., Carter, C. A., Berkowitz, N., Conan-Cibotti, M., Cox, J. H., Beck, A., O’Callahan, M., Andrews, C., Gordon, I. J., Larkin, B., Lampley, R., Kaltovich, F., Gall, J., Carlton, K., Mendy, J., Haney, D., May, J., & Bray, A. (2020). Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 323(14), 1369–1377. https://doi.org/10.1001/jama.2020.2477
Chicago
Chen, Grace L., Emily E. Coates, Sarah H. Plummer, Cristina A. Carter, Nina Berkowitz, Michelle Conan-Cibotti, Josephine H. Cox, et al. 2020. “Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.” JAMA: Journal of the American Medical Association 323 (14): 1369–77. doi:10.1001/jama.2020.2477.